ArticleScientific reports2025
Applicability of phase 3 trial selection criteria to real-world transthyretin amyloid cardiomyopathy patients.
Michael Poledniczek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it